0001209191-20-036641.txt : 20200615 0001209191-20-036641.hdr.sgml : 20200615 20200615164532 ACCESSION NUMBER: 0001209191-20-036641 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200611 FILED AS OF DATE: 20200615 DATE AS OF CHANGE: 20200615 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Treco Douglas A CENTRAL INDEX KEY: 0001688192 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37923 FILM NUMBER: 20963932 MAIL ADDRESS: STREET 1: 87 CAMBRIDGEPARK DRIVE STREET 2: C/O RA PHARMACEUTICALS, INC. CITY: CAMBRIDGE STATE: MA ZIP: 02140 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CRISPR Therapeutics AG CENTRAL INDEX KEY: 0001674416 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 473173478 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: BAARERSTRASSE 14 CITY: ZUG STATE: V8 ZIP: CH-6300 BUSINESS PHONE: 6173154600 MAIL ADDRESS: STREET 1: BAARERSTRASSE 14 CITY: ZUG STATE: V8 ZIP: CH-6300 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-06-11 0 0001674416 CRISPR Therapeutics AG CRSP 0001688192 Treco Douglas A C/O CRISPR THERAPEUTICS 610 MAIN STREET CAMBRIDGE MA 02139 1 0 0 0 Stock Option (Right to Buy) 59.70 2020-06-11 4 A 0 30000 0.00 A 2030-06-11 Common Shares 30000 30000 D This option was granted on June 11, 2020 with respect to 30,000 Common Shares with 100% of the shares vesting in 36 equal monthly installments. /s/ Michael Esposito, attorney-in-fact 2020-06-15